Generating Digital Twins with Multiple Sclerosis Using Probabilistic Neural Networks

by   Jonathan R. Walsh, et al.

Multiple Sclerosis (MS) is a neurodegenerative disorder characterized by a complex set of clinical assessments. We use an unsupervised machine learning model called a Conditional Restricted Boltzmann Machine (CRBM) to learn the relationships between covariates commonly used to characterize subjects and their disease progression in MS clinical trials. A CRBM is capable of generating digital twins, which are simulated subjects having the same baseline data as actual subjects. Digital twins allow for subject-level statistical analyses of disease progression. The CRBM is trained using data from 2395 subjects enrolled in the placebo arms of clinical trials across the three primary subtypes of MS. We discuss how CRBMs are trained and show that digital twins generated by the model are statistically indistinguishable from their actual subject counterparts along a number of measures.



There are no comments yet.


page 4


Modeling Disease Progression in Mild Cognitive Impairment and Alzheimer's Disease with Digital Twins

Alzheimer's Disease (AD) is a neurodegenerative disease that affects sub...

Comparison of Time-to-First-Event and Recurrent Event Methods in Multiple Sclerosis Trials

Suppression of disability progression is an important goal in the treatm...

Longitudinal modeling of MS patient trajectories improves predictions of disability progression

Research in Multiple Sclerosis (MS) has recently focused on extracting k...

Multimodal Machine Learning-based Knee Osteoarthritis Progression Prediction from Plain Radiographs and Clinical Data

Knee osteoarthritis (OA) is the most common musculoskeletal disease with...

Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis

Prognosis on the occurrence of relapses in individuals with Relapsing-Re...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.